Source: Contract Pharma

Bruker: Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles

iNTApharma provides single-particle sensitivity for quantitative analysis in native aqueous media.

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Frank H Laukien's photo - Chairman & CEO of Bruker

Chairman & CEO

Frank H Laukien

CEO Approval Rating

78/100

Read more